Response to the letter to the editor.

[1]  R. Abouqal,et al.  Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco. , 2020, Journal of infection and public health.

[2]  K. Zerouali,et al.  Streptococcus pneumoniae carriage among febrile children at the time of PCV-10 immunization in pediatric emergencies at Mohammed VI University Hospital Centre in Marrakesh (Morocco). , 2019, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[3]  K. Zerouali,et al.  A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine , 2017, BMC Pediatrics.

[4]  M. Timinouni,et al.  Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco , 2017, Annals of Clinical Microbiology and Antimicrobials.

[5]  Q. Bassat,et al.  Streptococcus pneumoniae carriage among healthy and sick pediatric patients before the generalized implementation of the 13-valent pneumococcal vaccine in Morocco from 2010 to 2011. , 2017, Journal of infection and public health.

[6]  M. Timinouni,et al.  Phenotypic and genotypic characterization of Streptococcus pneumoniae resistant to macrolide in Casablanca, Morocco. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  K. Katfy,et al.  Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  K. Zerouali,et al.  [Meningitis caused by Streptococcus pneumoniae serotype 7a in an infant vaccinated with two doses of 13-valent pneumococcal conjugate vaccine: a case study]. , 2019 .